CN110582306A - 修饰的mri造影剂及其用途 - Google Patents

修饰的mri造影剂及其用途 Download PDF

Info

Publication number
CN110582306A
CN110582306A CN201880027317.0A CN201880027317A CN110582306A CN 110582306 A CN110582306 A CN 110582306A CN 201880027317 A CN201880027317 A CN 201880027317A CN 110582306 A CN110582306 A CN 110582306A
Authority
CN
China
Prior art keywords
compound
sub
protein
composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880027317.0A
Other languages
English (en)
Chinese (zh)
Inventor
C·L·M·勒古雅德
N·C·詹内斯基
C·E·考尔曼
M·P·汤普森
特雷弗·迪特里
P·A·伯廷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vybyl Inc
University of California San Diego UCSD
Original Assignee
Vybyl Inc
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vybyl Inc, University of California San Diego UCSD filed Critical Vybyl Inc
Publication of CN110582306A publication Critical patent/CN110582306A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A61K49/108—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA the metal complex being Gd-DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
CN201880027317.0A 2017-04-27 2018-04-25 修饰的mri造影剂及其用途 Pending CN110582306A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762491159P 2017-04-27 2017-04-27
US62/491,159 2017-04-27
PCT/US2018/029271 WO2018200615A2 (en) 2017-04-27 2018-04-25 Modified mri contrast agents and uses thereof

Publications (1)

Publication Number Publication Date
CN110582306A true CN110582306A (zh) 2019-12-17

Family

ID=63920047

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880027317.0A Pending CN110582306A (zh) 2017-04-27 2018-04-25 修饰的mri造影剂及其用途

Country Status (9)

Country Link
US (1) US20200046859A1 (https=)
EP (1) EP3615088A4 (https=)
JP (1) JP2020517584A (https=)
KR (1) KR20190135500A (https=)
CN (1) CN110582306A (https=)
AU (1) AU2018258345A1 (https=)
CA (1) CA3057976A1 (https=)
SG (1) SG11201908911QA (https=)
WO (1) WO2018200615A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2998528A1 (en) * 2015-09-22 2017-03-30 The Regents Of The University Of California Modified cytotoxins and their therapeutic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
JP3404787B2 (ja) * 1993-03-12 2003-05-12 三菱ウェルファーマ株式会社 新規ジエチレントリアミンペンタ酢酸誘導体、該誘導体と金属原子との錯化合物、及び該錯化合物を含む診断剤
AU726914B2 (en) * 1996-04-01 2000-11-23 Epix Pharmaceuticals, Inc. Bioactivated diagnostic imaging contrast agents
DE19652387A1 (de) * 1996-12-04 1998-06-10 Schering Ag Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung
US20030021750A1 (en) * 2001-04-04 2003-01-30 Bakan Douglas A. Novel functional agents for magnetic resonance imaging
JP5291930B2 (ja) * 2005-03-09 2013-09-18 独立行政法人科学技術振興機構 錯化合物及びそれから成るｍｒｉプローブ
WO2008144728A1 (en) * 2007-05-21 2008-11-27 Bracco Imaging S.P.A. Conjugates which bind a blood protein such as human serum albumin and methods of using the same in diagnostic and therapeutic applications

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AKANKSHA JAIN等: "68Ga labeled fatty acids for cardiac metabolic imaging: Influence of different bifunctional chelators", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
MAXIM L. BELYANIN等: "Design, synthesis and evaluation of a new Mn – Contrast agent for MR imaging of myocardium based on the DTPA-phenylpentadecanoic acid complex", 《CHEMICAL PHYSICS LETTERS》 *
PETER CARAVAN等: "《The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging》", 31 December 2013, JOHN WILEY & SONS, LTD *

Also Published As

Publication number Publication date
WO2018200615A3 (en) 2019-01-10
EP3615088A4 (en) 2021-01-27
CA3057976A1 (en) 2018-11-01
US20200046859A1 (en) 2020-02-13
KR20190135500A (ko) 2019-12-06
SG11201908911QA (en) 2019-11-28
EP3615088A2 (en) 2020-03-04
AU2018258345A1 (en) 2019-10-17
JP2020517584A (ja) 2020-06-18
WO2018200615A2 (en) 2018-11-01

Similar Documents

Publication Publication Date Title
JP5879268B2 (ja) マンガンキレート並びに磁気共鳴イメージング（ｍｒｉ）における造影剤としての使用
CN102239138A (zh) 自磁性金属salen络合物
US10654864B2 (en) Modified cytotoxins and their therapeutic use
CN105491999A (zh) 用于癌症治疗的多西他赛聚合纳米颗粒
US9655980B2 (en) Theranostic platform for targeted cancer therapy and drug delivery monitoring
CN101862461B (zh) 用于淋巴系统特异成像的含钆大分子造影剂及其制备方法
CN110582306A (zh) 修饰的mri造影剂及其用途
US20210137957A1 (en) Modified anthracycline compounds and their therapeutic use
CN110636865A (zh) 修饰的寡核苷酸及其治疗用途
HK40019846A (en) Modified mri contrast agents and uses thereof
US20190381179A1 (en) Modified cytotoxins and their therapeutic use
WO2018175589A1 (en) Modified peptides and uses thereof for treating cancer
US20210137874A1 (en) Modified platinum compounds and therapeutic uses thereof
KR101159068B1 (ko) 분자영상 프로브 제조용 신규 리간드, 그 리간드를 포함하는 분자영상 프로브, 그 분자영상 프로브를 포함하는 분자영상 입자, 그 제조방법 및 그것을 포함하는 약학 조성물
Rossi et al. Poly (ethylene-glycol)-based fluorinated esters: a readily available entry for novel 19F-MRI agents
US20200048198A1 (en) Modified histone deacetylase inhibitors and uses thereof
Islam et al. Nanostructured gadolinium (III) micelles: Synthesis, characterization, cytotoxic activities, and MRI applications in vivo
WO2021007322A1 (en) Methods of using modified cytotoxins to treat cancer
EP3893938A1 (en) Antifolate-carrying nanoparticles and their use in medicine
You et al. A new magnetic resonance imaging probe specifically targeting vascular endothelial growth factor receptor 2: synthesis, characterization and biological evaluation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40019846

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20191217